同时抑制SO2氧化和改善deNOx 通过Ce和P化方式对VMo/Ti催化剂的活性
Wenjie Liao1, Ling Zhou1,2, Xiaoqiang Wang1,3
1Key Laboratory of Environment Remediation and Ecological Health, Ministry of Education, College of Environmental and Resource Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, P. R. China.
Environmental science & technology
|May 21, 2025
概括
这项研究开发了一种新的VMoCeP/Ti催化剂,用于NOx的氨选择性催化还原 (NH3-SCR). 优化的催化剂显示出高NOx转化率和显著减少的SO3排放,解决了工业应用中的关键挑战.
科学领域:
- 催化剂是一种催化剂.
- 环境化学环境化学
- 材料科学 材料科学 材料科学
背景情况:
- 使用NH3的NOx选择性催化降低 (SCR) 对于排放控制至关重要.
- 挑战包括保持高活性和最大限度地减少SO3在V-Ti基催化剂中的形成.
- 二氧化碳排放有助于催化剂的失活和环境污染.
研究的目的:
- 为NH3-SCR开发一种改进的基于V-Ti的催化剂,具有增强的活性和减少的SO3排放.
- 调查Ce和P修改对催化剂性能的合作效应.
- 阐明提高SCR效率和抑制SO2氧化背后的机制.
主要方法:
- 合成Ce和P联合修改的VMo/Ti催化剂.
- 在特定温度范围内 (250-350°C) 评估NOx在NH3-SCR中的催化性能.
- 分析催化剂特性,包括表面酸度,氧化还原能力和瓦纳迪尔物种的物种化.
主要成果:
- 最佳的VMoCeP/Ti催化剂实现了>95%的NOx转化.
- 保持SO2氧化比低于1.0%的情况.
- 增强的表面酸度和氧化还原特性促进了NH3的吸附和激活.
- 通过增加硫酸瓦纳物种的分解能量屏障,Ce和P联合剂改变了瓦纳基物种结构,并抑制了SO2氧化.
结论:
- Ce和P的共同修改有效地增强了NH3-SCR活性,并抑制了SO2的氧化.
- 修改后的催化剂提供了一个有前途的解决方案,可以有效地减少NOx,同时减少低SO3排放.
- 这项研究为设计用于工业应用的先进SCR催化剂提供了宝贵的见解.
相关概念视频
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.5K
01:30Enzyme Inhibition
77.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
77.7K
00:46Feedback Inhibition
53.5K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
53.5K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
506
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
506
01:30Combined Effects of Drugs: Antagonism
8.2K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.2K
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.4K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.4K